In 2004, the American Diabetes Association found that Zyprexa was more likely to cause diabetes than many other antipsychotic drugs.
A big hurdle with the Zyprexa issue is Lilly's credibility over their continuous PR on how they are going to pay out $1.2 billion . As long as they keep up this rhetoric and don't actually pay the issue won't go away.
They need to think about 'putting their money where their mouth is'.
Daniel Haszard www.zyprexa-victims.com
Home | Login | Contact Us | Forum
© 2001-2016 Joplin Independent